Innovative 'Montreal Model' Enhances Durability of Ketamine-Based Depression Treatment
The Montreal Model of ketamine therapy combines psychotherapy and supportive environments, leading to more sustained relief from severe depression and treatment resistance.
Recent clinical research led by McGill University introduces the 'Montreal Model,' a novel approach to ketamine therapy for severe depression. The study demonstrates that combining ketamine infusions with psychotherapy and a therapeutic environment significantly extends the duration of antidepressant effects. Participants with treatment-resistant depression, many experiencing suicidal thoughts, showed an average depression score reduction of approximately 30%, with improvements in suicidality and anxiety. Notably, these effects persisted for at least eight weeks, unlike conventional ketamine treatments where benefits often diminish within days.
The study emphasizes the importance of the treatment environment—rooms designed with calming lighting, plants, curated music or guided mindfulness—alongside regular psychotherapy sessions. This approach underscores the significance of psychological context in treatment outcomes.
Developed during residencies at McGill by Dr. Greenway and Dr. Garel, the Montreal Model integrates traditional psychiatry with strategies inspired by psychedelic therapy, including creating safe, supportive spaces for patients. The model has been successfully applied in both public and private healthcare settings in Canada and internationally.
An intriguing aspect of the research is the link between the subjective mystical or emotional experiences during ketamine sessions and positive therapeutic outcomes. These findings challenge the traditional view of such experiences as mere side effects, suggesting they may be integral to the healing process.
The study's positive results support the adoption of structured, environment-centric ketamine treatments, offering a promising path for managing complex, treatment-resistant depression. It also highlights the need for standardized protocols as ketamine clinics proliferate across Canada and beyond.
For further information, see the original source at
https://medicalxpress.com/news/2025-06-montreal-ketamine-therapy-yields-sustained.html
source: https://medicalxpress.com/news/2025-06-montreal-ketamine-therapy-yields-sustained.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Children Born to Parents with Mental Health Disorders Face Increased Risk of Premature Death
A large-scale Swedish study reveals that children of parents with mental health disorders face a higher risk of premature death, calling for targeted family support and mental health interventions.
Analysis of Substance Use and Mental Health Themes in Popular Music Since 2013
A study reveals how pop music from 2013 to 2024 reflects societal trends in substance use and mental health, highlighting its potential role in public health initiatives.
Am I Experiencing Insomnia? Five Reasons You Might Not Be
Discover the key reasons why your sleep issues may not actually be insomnia and learn when to seek professional help for chronic sleep problems.
Innovative Machine Learning Model Enhances Detection of Postpartum Depression Risk
A new machine learning model developed by Mass General Brigham researchers offers a promising tool for early detection of postpartum depression, leveraging accessible clinical data to improve maternal mental health outcomes.